Guanfacine Tablet, Extended Release
Product Images NDC 70436-040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 70436-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1mg-100ct.jpg (1mg 100ct)

1mg-100ct.jpg (1mg 100ct)
This is a medication, Guanfacine Extended-Release Tablets, manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and distributed by Slate Run Pharmaceuticals in Columbus, Ohio. Each tablet contains 1 mg of guanfacine hydrochloride, USP, and should not be crushed, chewed, or broken before swallowing. The package insert contains complete prescribing information, and the tablets must be stored at 20-25°C (68-77°F) and dispensed in a tight, light-resistant container with a child-resistant closure. The text at the end appears to be a random assortment of characters and is not informative.*
FDA Label Image

2mg-100ct (2mg 100ct)

2mg-100ct (2mg 100ct)
Each tablet of this medicine contains 2mg of guanfacine hydrochloride, USP. It is an extended-release drug and its complete prescribing information can be found in its package insert. The tablets should not be chewed, crushed or broken before swallowing. They should be kept at a temperature range of 20°C to 25°C and dispensed in a tight, light-resistant container out of children's reach. The manufacturer is Yichang Humanwell Oral Solid Dosage Plant, China 443112 and it is distributed by Slate Run Pharmaceuticals, LLC, Columbus, Ohio.*
FDA Label Image

3mg-100ct (3mg 100ct)

3mg-100ct (3mg 100ct)
This is a description for Guanfacine Extended-Release Tablets, manufactured by Yichang Humanwell Oral Solid Dosage Plant, Yichang, Hubei, China 443112 and distributed by Slate Run Pharmaceuticals, LLC, Columbus, Ohio 43215. The Tablets come in a secure package containing 100 Tablets, with each extended-release tablet containing 3 mg guanfacine as guanfacine hydrochloride, USP. Usual Dosage: SEE PACKAGE INSERT FOR COMPLETE PRESCRIBING INFORMATION. Tablets should not be crushed, chewed or broken before swallowing. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Keep this and all drugs out of the reach of children.*
FDA Label Image

4mg-100ct (4mg 100ct)

4mg-100ct (4mg 100ct)
Each extended-release tablet contains 4 mg of guanfacine hydrochloride, USP. The tablets should be stored at 20° to 25°C (68° to 77°F) and dispensed in a tight, light-resistant container with a child-resistant closure. They should not be crushed, chewed or broken before swallowing. The drug is manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and distributed by Slate Run Pharmaceuticals in Columbus, Ohio.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This appears to be a graph or chart displaying the time (in hours) and dosages (in milligrams) for two types of guanfacine medication: an extended-release form and an immediate-release form. The dosages listed are 1mg QD for both forms. There is no meaningful context or explanation provided beyond this.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.